Početna › Atrijska fibrilacija › Alabama
Kliničke studije za Atrijska fibrilacija u državi Alabama
11 studija za Atrijska fibrilacija traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Advanced Cardiovascular, Alexander City
- SEC Clinical Research, Dothan
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07175428A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Grandview Medical Center, Birmingham
U tijeku regrutacija
Od 18 do 80 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Alabama at Birmingham, Birmingham
- Grandview Medical Center, Birmingham
- Cardiology Associates of Mobile, Mobile
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT04088071Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- University of Alabama at Birmingham (UAB) Hospital, Birmingham
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 31. srp 2026. · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Grandview, Birmingham
U tijeku regrutacija
Od 18 do 80 godina · Oba spola · Ažurirano 15. srp 2026. · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1040, Birmingham
- Anthos Investigational site 9939, Birmingham
- Anthos Investigative Site 9947, Birmingham
- i još 1
U tijeku regrutacijaFaza 3
Od 65 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Huntsville Hospital, Huntsville
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Alabama Hospital, Birmingham
- University of South Alabama University Hospital, Mobile
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. svi 2026. · NCT03907046The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Arrhythmia Institute at Grandview, Birmingham
- Mobile Cardiology Associates, Mobile
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 31. lis 2025. · NCT06324201Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.